中国继续医学教育
中國繼續醫學教育
중국계속의학교육
CHINA CONTINUING MEDICAL EDUCATION
2015年
11期
215-216
,共2页
美罗培南%替加环素%新生儿
美囉培南%替加環素%新生兒
미라배남%체가배소%신생인
Meropenem%Tigecycline%Newborn
目的:探讨美罗培南结合替加环素治疗新生儿重症多重耐药菌感染的临床疗效。方法98例严重细菌感染的新生儿患者,分为对照组与观察组,观察两组治疗后的总有效率与不良反应情况。结果98例患者均获得细菌学检查阳性结果,差异具有统计学意义(P<0.05)。结论美罗培南治疗新生儿重症多重耐药菌感染安全有效。
目的:探討美囉培南結閤替加環素治療新生兒重癥多重耐藥菌感染的臨床療效。方法98例嚴重細菌感染的新生兒患者,分為對照組與觀察組,觀察兩組治療後的總有效率與不良反應情況。結果98例患者均穫得細菌學檢查暘性結果,差異具有統計學意義(P<0.05)。結論美囉培南治療新生兒重癥多重耐藥菌感染安全有效。
목적:탐토미라배남결합체가배소치료신생인중증다중내약균감염적림상료효。방법98례엄중세균감염적신생인환자,분위대조조여관찰조,관찰량조치료후적총유효솔여불량반응정황。결과98례환자균획득세균학검사양성결과,차이구유통계학의의(P<0.05)。결론미라배남치료신생인중증다중내약균감염안전유효。
ObjectiveTo investigate the meropenem combined with tigecycline clinical curative effect in the treatment of multi drug resistant strains of severe neonatal infection. Methods 98 cases treated in our hospital in patients with severe bacterial infections in neonates, Divided into control group and observation group, the observation group two after treatment, the total efficiency and adverse reaction. Results98 patients showed positive results of bacteriological examination, with significant difference (P<0.05).Conclusion Meropenem treatment of neonatal severe multi drug resistant bacteria infection is safe and effective.